The coagulation system of extremely preterm infants: Influence of perinatal risk factors on coagulation

Journal of Perinatology

Volumn 32, Issue 11, 2012, Pages 869-873

  Poralla, C ^a   Traut, C ^a   Hertfelder, H J ^a   Oldenburg, J ^a   Bartmann, P ^a   Heep, A ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Coagulation; extremely preterm infants; inflammation; perinatal risk factors; vitamin K

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTHROMBIN; VITAMIN K GROUP;

ARTICLE; BLOOD CLOTTING; CHORIOAMNIONITIS; COHORT ANALYSIS; CONTROLLED STUDY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PERINATAL PERIOD; PLACENTA DISORDER; PREMATURITY; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK FACTOR;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CHORIOAMNIONITIS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; PLACENTA; PLACENTA DISEASES; PREGNANCY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; UTERUS;

EID: 84868593806     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.182     Document Type: Article

References (12)

1. Hassan HJ, Leonardi A, Chelucci C, Mattia G, Macioce G, Guerriero R et al. Coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Blood 1990; 76:1158-1164.
2. Andrew M, Paes B, Milner R, Johnston M, Mitchell L. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72:1651-1657.
3. Andrew M, Paes B, Milner R, Johnston M, Mitchell L. Development of the human coagulation system in the full-term infant. Blood 1987; 70:165-172.
4. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors on the healthy human fetus. Blood 1996; 88:900-906.
5. Forestier F, Daffos F, Galactéros F, Bardakjian J, Rainaut M, Beuzard Y. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986; 20:342-346.
6. Barnard DR, Simmons MA, Hathaway WE. Coagulation studies in extremely premature infants. Pediatr Res 1979; 13:1330-1335.
7. Salonvaara M, Riikonen P, Kekomaeki R, Vahtera E, Mahlamaeki E, Halonen P. Effects of gestational age and prenatal and perinatal events on the coagulation status in preterm infants. Arch Dis Child Fetal Neonatal Ed 2003; 88: F319-F323.
8. Tanjung MT, Siddik HD, Hariman H, Koh SC. Coagulation and fibrinolysis in preeclampsia and neonates. Clin Appl Thromb Hemost 2005; 11:467-473.
9. Higgins JR, Bonnar J, Norris LA, Darling MR, Walshe JJ. The effect of pre-eclampsia on coagulation and fibrinolytic activation in the neonate. Thromb Res 2000; 99:567-570.
10. Seguin JH, Topper WH. Coagulation studies in very low-birth weight infants. Am J Perinatol 1994; 11:27-29.
11. Egarter C, Leitich H, Husslein P, Kaider A, Schemper M. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: a meta-analysis. Obstet Gynecol 1996; 88:303-309.
12. Martius JA, Roos T, Gora B, Oehler MK, Schrod L, Papadopoulos T et al. Risk factors associated with early-onset sepsis in premature infants. Eur J Obstet Gynecol Reprod Biol 1999; 85:151-158.